Silybin, a new iron-chelating agent

被引:95
|
作者
Borsari, M
Gabbi, C
Ghelfi, F
Grandi, R
Saladini, M
Severi, S
Borella, F
机构
[1] Univ Modena, Dipartimento Chim, I-41100 Modena, Italy
[2] Ist Biochim Italiano, Milan, Italy
关键词
silybin; iron chelator; chronic iron overload; Cooley's anemia;
D O I
10.1016/S0162-0134(01)00198-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Silybin, a natural occurring flavolignan isolated from the fruits of Silibum marianum, has been reported to exert antioxidant and free radical scavenging abilities. It was suggested to act also as an iron chelator. The complexation and protonation equilibria of the ferric complex of this compound have been studied by potentiometric, spectrophotometric and electrochemical techniques. The formation of the complex silybin-Ga(III) in anhydrous DMSO-d6 has been studied by H-1 NMR spectroscopy. Mass spectrometry and infrared spectroscopy on silybin-Fe(III) complex confirm all data obtained by H-1 NMR spectroscopy. The experimental results show that silybin binds Fe(III) even at acidic pH. Different ternary complexes were observed at increasing methoxide ion concentration and their stability constants have been calculated. The results show the possible role of silybin in relation to the chelation therapy of chronic iron overload, as occurs in the treatment of Cooley's anemia. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 50 条
  • [21] Iron-Chelating Therapy for Transfusional Iron Overload
    Solomon, Lawrence R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (15): : 1475 - 1476
  • [22] Iron-Chelating Therapy for Transfusional Iron Overload
    Brittenham, Gary M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (02): : 146 - 156
  • [23] EVALUATION OF IRON-CHELATING AGENTS IN AN INVIVO SYSTEM - POTENTIAL USEFULNESS OF EHPG, A POWERFUL IRON-CHELATING DRUG
    HERSHKO, C
    GRADY, RW
    LINK, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) : 251 - 260
  • [24] 3D-QSAR studies of chromone derivatives as iron-chelating agent
    Phosrithong, Narumol
    Ungwitayatorn, Jiraporn
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (02) : 1037 - 1045
  • [25] DIFFERENT IRON-CHELATING PROPERTIES OF AMINOSALICYLATES
    ALLGAYER, H
    GUGLER, R
    BOHNE, P
    SCHMIDT, M
    KRUIS, W
    GASTROENTEROLOGY, 1992, 103 (06) : 1991 - 1992
  • [26] 3D-QSAR studies of chromone derivatives as iron-chelating agent
    Narumol Phosrithong
    Jiraporn Ungwitayatorn
    Medicinal Chemistry Research, 2014, 23 : 1037 - 1045
  • [27] NOVEL IRON-CHELATING GRAFT COPOLYMER
    RAMIREZ, RS
    ANDRADE, JD
    JOURNAL OF MACROMOLECULAR SCIENCE-CHEMISTRY, 1973, A 7 (05): : 1035 - 1045
  • [28] Iron-chelating therapy and the treatment of thalassemia
    Olivieri, NF
    Brittenham, GM
    BLOOD, 1997, 89 (03) : 739 - 761
  • [29] Iron-chelating agent, deferasirox, inhibits neutrophil activation and extracellular trap formation
    Kono, Mari
    Saigo, Katsuyasu
    Yamamoto, Shiori
    Shirai, Kohei
    Iwamoto, Shuta
    Uematsu, Tomoko
    Takahashi, Takayuki
    Imoto, Shion
    Hashimoto, Makoto
    Minami, Yosuke
    Wada, Atsushi
    Takenokuchi, Mariko
    Kawano, Seiji
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2016, 43 (10): : 915 - 920
  • [30] THE DESIGN OF POTENTIAL IRON-CHELATING DRUGS
    BHARGAVA, KK
    GRADY, RW
    CERAMI, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1980, 180 (AUG): : 106 - MEDI